Evolus, Inc. (LON:0K16)
London flag London · Delayed Price · Currency is GBP · Price in USD
14.58
+0.43 (3.00%)
At close: Jan 31, 2025

Evolus Company Description

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels.

The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Evolus, Inc.
CountryUnited States
Founded2012
IndustryMedical - Pharmaceuticals
SectorHealthcare
Employees332
CEODavid Moatazedi

Contact Details

Address:
520 Newport Center Drive
Newport Beach, Delaware 92660
United States
Phone949 284 4555
Websiteevolus.com

Stock Details

Ticker Symbol0K16
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS30052C1071
SIC Code2834

Key Executives

NamePosition
David MoatazediChief Executive Officer
Nareg SagherianHead of Investor Relations